Analyst Rating
based on 31 analysts
70.97%
Buy
19.35%
Hold
9.68%
Sell
Based on 31 analysts offering long term price targets for Torrent Pharmaceuticals Ltd. An average target of ₹3286.16
Source: S&P Global Market Intelligence
Torrent Pharmaceuticals Ltd Share analysis
Torrent Pharmaceuticals Ltd price forecast by 31 analysts
Downside of
High
₹3940
Target
₹3286.16
Low
₹2775
Torrent Pharmaceuticals Ltd target price ₹3286.16, a slight downside of -4.8% compared to current price of ₹3451.4. According to 31 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Torrent Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:26.81%
Forecast
Actual
Including amortisation and stock based compensations
Torrent Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2026:60.30%
Forecast
Actual
Source: S&P Global Market Intelligence
Performance
Day's Low
Day's High
₹3,440.65₹3,483.0552 Week's Low
52 Week's High
₹1,821.45₹3,574
| Returns % | |
| 1 Month Return | + 3.09 % |
| 3 Month Return | + 19.57 % |
| 1 Year Return | + 83.17 % |
| Market Stats | |
| Previous Close | ₹3,451.70 |
| Open | ₹3,452.70 |
| Volume | 2.00L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,16,815.97Cr |
Key Statistics
| P/E Ratio | 67.32 |
| PEG Ratio | 4.89 |
| Market Cap | ₹1,16,815.97 Cr |
| P/B Ratio | 12.89 |
| EPS | 48.94 |
| Dividend Yield | 1.08 |
| Sector | Pharmaceuticals |
| ROE | 20.43 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,16,815.97 Cr | 60.76% | 0.67 | ₹1,656 Cr | ₹10,727 Cr | |
| HOLD | ₹1,45,971.88 Cr | 46.86% | 0.50 | ₹1,600 Cr | ₹7,845 Cr | |
| HOLD | ₹45,496.74 Cr | 12.83% | 0.58 | ₹1,297 Cr | ₹14,755 Cr | |
| HOLD | ₹30,944.49 Cr | 0.65% | 0.50 | ₹772 Cr | ₹5,664 Cr | |
| BUY | ₹1,34,030.72 Cr | 50.55% | 0.50 | ₹4,155 Cr | ₹25,774 Cr |
Company Information
The company is focused on producing high-quality, affordable medicines for the treatment of a wide range of diseases. Its top products include cardiovascular drugs, antibiotics, anti-diabetic drugs, anti-inflammatory drugs, and anti-infective drugs. Popular brands include Cadila, Torleva, Torlip, and Torleva XR.
Share Price: ₹3451.40 per share as on 16 Sep, 2024 03:23 PM
Market Capitalisation: ₹1,16,815.97Cr as of today
Revenue: ₹2,815.00Cr as on June 2024 (Q2 24)
Net Profit: ₹457.00Cr as on June 2024 (Q2 24)
Listing date: 03 Nov, 1994
Chairperson Name: Sudhir Mehta
| Organisation | Torrent Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Torrent Pharmaceuticals Ltd
Torrent Group Promoters' Net Worth Surges - 04 Sep, 2024
The net worth of Torrent Group promoters increased by 126.2% to ₹1,41,694 crore, driven by a rally in shares of Torrent Pharmaceuticals and Torrent Power. Torrent Pharma, a key player in the market, generated ₹10,785 crore in FY24, contributing significantly to group revenues and market cap.
Torrent Pharma Receives Positive FDA Clearance - 02 Sep, 2024
Nomura maintains a neutral call on Torrent Pharma with a target price of ₹3,018 per share. The company expects 5-10 new product approvals in FY25 and anticipates revenue recovery in the US market, projecting sales of $133 million, $153 million, and $184 million for FY25, FY26, and FY27, respectively.
Torrent Pharma Shares Surge After USFDA EIR Issuance - 30 Aug, 2024
Torrent Pharmaceuticals' shares soared after the USFDA issued an Establishment Inspection Report with Voluntary Action Indicated classification for its Indrad facility, marking a successful inspection closure.
Insights on Torrent Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, TORNTPHARM stock has moved up by 83.2%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 6 quarters, 287.0 Cr → 457.0 Cr (in ₹), with an average increase of 8.4% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 2.77K Cr → 2.88K Cr (in ₹), with an average increase of 3.7% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, TORNTPHARM has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 14.14% to 14.22% in Jun 2024 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 71.25% of holdings in Jun 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 137.3% return, outperforming this stock by 15.7%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 4.46% to 4.35% in Jun 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 7.36% to 7.26% in Jun 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.25% | 0.00 | |
| Foreign Institutions | 14.22% | 0.61 | |
| Mutual Funds | 4.35% | ||
| Retail Investors | 7.26% | ||
| Others | 2.92% | 4.51 |
Key Indicators
Torrent Pharmaceuticals Ltd Valuation
Torrent Pharmaceuticals Ltd in the last 5 years
Lowest (31.60x)
April 2, 2018
Industry (58.76x)
September 13, 2024
Today (67.32x)
September 13, 2024
Highest (73.85x)
April 3, 2019
Earnings and Dividends
Torrent Pharmaceuticals Ltd Earnings Results
Torrent Pharmaceuticals Ltd’s net profit jumped 20.9% since last year same period to ₹457Cr in the Q1 2024-2025. On a quarterly growth basis, Torrent Pharmaceuticals Ltd has generated 1.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsTorrent Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Torrent Pharmaceuticals Ltd has declared dividend of ₹6 - translating a dividend yield of 1.04%.
Read More about Dividends
Technicals Summary
Bearish
Neutral
Bullish
Torrent Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Torrent Pharmaceuticals Ltd shares.
Torrent Pharmaceuticals Ltd (TORNTPHARM) share price today is ₹3451.4
Torrent Pharmaceuticals Ltd is listed on NSE
Torrent Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Torrent Pharmaceuticals Ltd is ₹3483.05.
- Today’s lowest price of Torrent Pharmaceuticals Ltd is ₹3440.65.
PE Ratio of Torrent Pharmaceuticals Ltd is 67.32
PE ratio = Torrent Pharmaceuticals Ltd Market price per share / Torrent Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Torrent Pharmaceuticals Ltd(TORNTPHARM) is 2.00L.
Today’s market capitalisation of Torrent Pharmaceuticals Ltd(TORNTPHARM) is ₹116815.97Cr.
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Price |
|---|---|
52 Week High | ₹3574 |
52 Week Low | ₹1821.45 |
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3451.4. It is down -3.43% from its 52 Week High price of ₹3574
Torrent Pharmaceuticals Ltd(TORNTPHARM) share price is ₹3451.4. It is up 89.49% from its 52 Week Low price of ₹1821.45
| Torrent Pharmaceuticals Ltd(TORNTPHARM | Returns |
|---|---|
1 Day Returns | -0.3% |
1 Month Returns | 3.09% |
3 Month Returns | 19.57% |
1 Year Returns | 83.17% |